Drug intelligence / Profile preview

Artelac (Bausch + Lomb)

Development stage: Unknown
Lead developer: Bausch + Lomb
Administration: Ophthalmic

Overview

**Artelac** is a Bausch + Lomb ophthalmic-lubricant brand family used for symptomatic management of **dry eye disease**. The exact formulation is market- and product-specific: products sold under the Artelac name include hypromellose eye drops and lipid-containing lubricating gels or drops containing carbomer and medium-chain triglycerides; other Artelac variants contain additional tear-film-supporting ingredients. These products act locally as artificial tears, improving ocular-surface lubrication, retaining moisture, and, in lipid-containing formulations, supporting the tear-film lipid layer to reduce evaporation.

Brand names: Artelac

Beyond the preview

Go deeper on Artelac (Bausch + Lomb).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Artelac (Bausch + Lomb).

Explore the full profile